ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
Dow Jones
38.239,66
0,40%
Euro vs US Dollar
1,06965
0,00%
Bitcoin
63.679,29
0,42%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE
  6. Hikma Pharmaceuticals Plc (HIK)

  7. Hikma Pharmaceuticals Plc (HIK) News

HIK Hikma Pharmaceuticals Plc

1.913,00
59,00 (3,18%)
26 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Hikma Pharmaceuticals Plc HIK London Ordinary Share
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
59,00 3,18% 1.913,00 17:35:11
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1.861,00 1.861,00 1.920,00 1.913,00 1.854,00
more quote information »
Industriesektor
PHARMACEUTICALS & BIOTECHNOLOGY

Aktuelle News

Datum Zeit Quelle Überschrift
25.4.202415:28UK RNSHikma Pharmaceuticals Plc Result of AGM
25.4.202411:15ALNCNewsHikma Pharmaceuticals backs outlook after making strong..
25.4.202408:00UK RNSHikma Pharmaceuticals Plc Trading Statement
17.4.202411:42UK RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
15.4.202417:43UK RNSHikma Pharmaceuticals Plc Hikma appoints new President of..
11.4.202411:58UK RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
02.4.202410:50UK RNSHikma Pharmaceuticals Plc Block listing Interim Review
22.3.202410:21UK RNSHikma Pharmaceuticals Plc Annual Financial Report and Notice..
13.3.202410:42UK RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
07.3.202414:52UK RNSHikma Pharmaceuticals Plc Director/PDMR Shareholding
01.3.202411:17UK RNSHikma Pharmaceuticals Plc Total Voting Rights
22.2.202410:42ALNCNewsTOP NEWS: Hikma boosts dividend after year of "significant..
22.2.202408:09ALNCNews*Hikma Pharmaceuticals says core operating profit to be in..
22.2.202408:00UK RNSHikma Pharmaceuticals Plc Final Results
21.2.202419:20UKREGHikma hosts White House Drug Policy Director Dr. Rahul Gupta..
20.2.202418:24ALNCNewsEARNINGS PREVIEW: Eyes on Hikma's outlook ahead of full-year..
05.2.202413:00UKREGHikma announces US launch of COMBOGESIC® IV
05.2.202409:46UK RNSHikma Pharmaceuticals Plc Notice of Results
01.2.202421:00ALNCNewsEARNINGS AND TRADING: Tandem FY sales down 17%; Hikma's..
01.2.202419:22UK RNSHikma Pharmaceuticals Plc Agreement in Principle for US..
01.2.202413:08UK RNSHikma Pharmaceuticals Plc Total Voting Rights
08.1.202408:30BWGuardant Health and Hikma Partner to Offer Cancer Screening..
02.1.202416:24UKREGHikma Pharmaceuticals Plc Total Voting Rights
29.12.202308:00UKREGHikma Pharmaceuticals Plc Company Secretary Change
01.12.202308:00UKREGHikma Pharmaceuticals Plc Total Voting Rights
02.11.202309:53ALNCNewsTOP NEWS: Hikma Pharmaceuticals upgrades Generics and..
02.11.202308:00UKREGHikma Pharmaceuticals Plc Trading Statement
03.10.202313:00PRNUSHikma marks two-year anniversary of KLOXXADO® launch by..
02.10.202311:13UKREGHikma Pharmaceuticals Plc Block listing Interim Review
02.10.202311:04UKREGHikma Pharmaceuticals Plc Total Voting Rights
01.9.202308:00UKREGHikma Pharmaceuticals Plc Total Voting Rights
31.8.202320:06UKREGHikma Pharmaceuticals Plc Director/PDMR Shareholding
30.8.202318:55ALNCNewsTOP NEWS: M&S returns to FTSE 100 after four years,..
23.8.202315:07ALNCNewsIN DEPTH: M&S set for blue-chip return as Hikma-Dechra yo-yo..
22.8.202318:26ALNCNewsTOP NEWS: M&S set to be FTSE 100 outfit again but Persimmon..
11.8.202315:00UKREGHikma Pharmaceuticals Plc Director/PDMR Shareholding
10.8.202317:53UKREGHikma Pharmaceuticals Plc Director/PDMR Shareholding
10.8.202314:28PRNUSRakuten Medical and Hikma Sign Exclusive Licensing Agreement..
09.8.202308:00UKREGHikma Pharmaceuticals Plc Hikma appoints new President of..
03.8.202310:28ALNCNewsHikma posts higher interim revenue; ups guidance for..
03.8.202308:00UKREGHikma Pharmaceuticals Plc Half-year Report
26.7.202318:45PRNUSHikma Ventures invests in Octave Bioscience, a precision..
17.7.202310:11UKREGHikma Pharmaceuticals Plc Notice of Results
15.6.202321:00PRNUSHikma exceeds 150 injectable medicines in the US with launch..
14.6.202311:03UKREGHikma Pharmaceuticals Plc Holding(s) in Company
08.6.202311:25UKREGHikma Pharmaceuticals Plc Director/PDMR Shareholding
31.5.202316:20UKREGHikma Pharmaceuticals Plc Director/PDMR Shareholding
23.5.202317:14UKREGHikma Pharmaceuticals Plc Holding(s) in Company
17.5.202310:56UKREGHikma Pharmaceuticals Plc Director/PDMR Shareholding
02.5.202311:53UKREGHikma Pharmaceuticals Plc Total Voting Rights

Kürzlich von Ihnen besucht

LSE
HIK
Hikma Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten